Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Gut ; 68(3): 522-532, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30301768

RESUMEN

OBJECTIVE: Sustained inflammation originating from macrophages is a driving force of fibrosis progression and resolution. Monoacylglycerol lipase (MAGL) is the rate-limiting enzyme in the degradation of monoacylglycerols. It is a proinflammatory enzyme that metabolises 2-arachidonoylglycerol, an endocannabinoid receptor ligand, into arachidonic acid. Here, we investigated the impact of MAGL on inflammation and fibrosis during chronic liver injury. DESIGN: C57BL/6J mice and mice with global invalidation of MAGL (MAGL -/- ), or myeloid-specific deletion of either MAGL (MAGLMye-/-), ATG5 (ATGMye-/-) or CB2 (CB2Mye-/-), were used. Fibrosis was induced by repeated carbon tetrachloride (CCl4) injections or bile duct ligation (BDL). Studies were performed on peritoneal or bone marrow-derived macrophages and Kupffer cells. RESULTS: MAGL -/- or MAGLMye-/- mice exposed to CCl4 or subjected to BDL were more resistant to inflammation and fibrosis than wild-type counterparts. Therapeutic intervention with MJN110, an MAGL inhibitor, reduced hepatic macrophage number and inflammatory gene expression and slowed down fibrosis progression. MAGL inhibitors also accelerated fibrosis regression and increased Ly-6Clow macrophage number. Antifibrogenic effects exclusively relied on MAGL inhibition in macrophages, since MJN110 treatment of MAGLMye-/- BDL mice did not further decrease liver fibrosis. Cultured macrophages exposed to MJN110 or from MAGLMye-/- mice displayed reduced cytokine secretion. These effects were independent of the cannabinoid receptor 2, as they were preserved in CB2Mye-/- mice. They relied on macrophage autophagy, since anti-inflammatory and antifibrogenic effects of MJN110 were lost in ATG5Mye-/- BDL mice, and were associated with increased autophagic flux and autophagosome biosynthesis in macrophages when MAGL was pharmacologically or genetically inhibited. CONCLUSION: MAGL is an immunometabolic target in the liver. MAGL inhibitors may show promising antifibrogenic effects during chronic liver injury.


Asunto(s)
Antiinflamatorios/uso terapéutico , Cirrosis Hepática Experimental/tratamiento farmacológico , Hígado/enzimología , Monoacilglicerol Lipasas/antagonistas & inhibidores , Animales , Antiinflamatorios/farmacología , Autofagia/efectos de los fármacos , Carbamatos/farmacología , Carbamatos/uso terapéutico , Tetracloruro de Carbono , Recuento de Células , Células Cultivadas , Citocinas/metabolismo , Progresión de la Enfermedad , Evaluación Preclínica de Medicamentos/métodos , Hidrolasas/metabolismo , Mediadores de Inflamación/antagonistas & inhibidores , Mediadores de Inflamación/metabolismo , Cirrosis Hepática Experimental/inducido químicamente , Cirrosis Hepática Experimental/enzimología , Cirrosis Hepática Experimental/patología , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Macrófagos/fisiología , Masculino , Ratones Endogámicos C57BL , Ratones Noqueados , Terapia Molecular Dirigida/métodos , Monoacilglicerol Lipasas/fisiología , Receptor Cannabinoide CB2/metabolismo , Succinimidas/farmacología , Succinimidas/uso terapéutico
2.
ACS Chem Neurosci ; 4(9): 1322-32, 2013 Sep 18.
Artículo en Inglés | MEDLINE | ID: mdl-23731016

RESUMEN

Monoacylglycerol lipase (MAGL) is a principal metabolic enzyme responsible for hydrolyzing the endogenous cannabinoid (endocannabinoid) 2-arachidonoylglycerol (2-AG). Selective inhibitors of MAGL offer valuable probes to further understand the enzyme's function in biological systems and may lead to drugs for treating a variety of diseases, including psychiatric disorders, neuroinflammation, and pain. N-Hydroxysuccinimidyl (NHS) carbamates have recently been identified as a promising class of serine hydrolase inhibitors that shows minimal cross-reactivity with other proteins in the proteome. Here, we explore NHS carbamates more broadly and demonstrate their potential as inhibitors of endocannabinoid hydrolases and additional enzymes from the serine hydrolase class. We extensively characterize an NHS carbamate 1a (MJN110) as a potent, selective, and in-vivo-active MAGL inhibitor. Finally, we demonstrate that MJN110 alleviates mechanical allodynia in a rat model of diabetic neuropathy, marking NHS carbamates as a promising class of MAGL inhibitors.


Asunto(s)
Amidohidrolasas/antagonistas & inhibidores , Carbamatos/farmacología , Endocannabinoides/metabolismo , Monoacilglicerol Lipasas/antagonistas & inhibidores , Succinimidas/farmacología , Animales , Glucemia/análisis , Encéfalo/efectos de los fármacos , Encéfalo/enzimología , Carbamatos/síntesis química , Carbamatos/química , Carbamatos/uso terapéutico , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/complicaciones , Neuropatías Diabéticas/sangre , Neuropatías Diabéticas/tratamiento farmacológico , Evaluación Preclínica de Medicamentos , Células HEK293 , Humanos , Hiperalgesia/tratamiento farmacológico , Insulina/sangre , Hígado/efectos de los fármacos , Hígado/enzimología , Masculino , Ratones , Estructura Molecular , Nocicepción/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Especificidad de la Especie , Relación Estructura-Actividad , Succinimidas/química , Succinimidas/uso terapéutico
3.
Nucl Med Biol ; 33(5): 615-24, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16843836

RESUMEN

INTRODUCTION: Androgen receptor (AR), which is overexpressed in most prostate cancers, is the target of androgen ablation and antiandrogen therapies: it is also the target for the receptor-mediated imaging of AR-positive prostate cancer using radiolabeled ligands. Previous AR imaging agents were based on a steroidal core labeled with fluorine. To develop a novel class of nonsteroidal imaging agents, with binding and pharmacological characteristics that are more similar to those of clinically used AR antagonists, we synthesized N-(3-fluoro-4-nitronaphthyl)-cis-5-norbornene-endo-2,3-dicarboxylic imide (3-F-NNDI), an analog of recently reported AR antagonist ligands. METHODS: 3-F-NNDI was synthesized in six steps starting with 1-nitronaphthalene, with fluorine incorporation as the final step. The labeling of 3-F-NNDI with fluorine-18 was achieved through a novel, extremely mild, S(N)Ar displacement reaction of an o-nitro-activated arene trimethylammonium salt, and 3-[(18)F]F-NNDI was prepared in high specific activity. RESULTS AND DISCUSSION: 3-F-NNDI was found to have an AR-binding affinity similar to that of its parent compound. In vitro assays demonstrated high stability of the labeled compound under physiological conditions in buffer and in the blood. Androgen target tissue uptake in diethylstilbestrol-pretreated male rats, however, was minimal, probably because of extensive metabolic defluorination the radiolabeled ligand. CONCLUSIONS: This study is part of our first look at a novel class of nonsteroidal AR antagonists as positron emission tomography (PET) imaging agents that are alternatives to steroidal AR agonist-based imaging agents. Although 3-[(18)F]F-NNDI has significant affinity for AR, it showed limited promise as a PET imaging agent because of its poor target tissue distribution properties.


Asunto(s)
Norbornanos/farmacocinética , Próstata/diagnóstico por imagen , Próstata/metabolismo , Receptores Androgénicos/metabolismo , Succinimidas/farmacocinética , Animales , Evaluación Preclínica de Medicamentos , Marcaje Isotópico/métodos , Masculino , Tasa de Depuración Metabólica , Norbornanos/química , Norbornanos/uso terapéutico , Especificidad de Órganos , Tomografía de Emisión de Positrones/métodos , Radiofármacos/síntesis química , Radiofármacos/farmacocinética , Radiofármacos/uso terapéutico , Ratas , Ratas Sprague-Dawley , Succinimidas/química , Succinimidas/uso terapéutico , Distribución Tisular
4.
Arch Pharm Res ; 27(3): 273-7, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15089029

RESUMEN

In previous studies for the development of new anticonvulsants, we found that N-Cbz-alpha-amino-N-alkylsuccinimides exhibited significant anticonvulsant activities in the Maximal electroshock seizure (MES) and Pentylenetetrazole induced seizure (PTZ) tests, and also their anticonvulsant activities were dependent on the N-alkyl substituents existent in their structures. Based on these estimations, N-Cbz-alpha-amino-N-hydroxysuccinimide and various N-Cbz-alpha-amino-N-alkoxysuccinimides were prepared in order to develop more active anticonvulsants and to examine the effects of N-hydoxy or N-alkoxy groups on their anticonvulsant activities. The (R)- or (S)-N-Cbz-alpha-amino-N-hydroxysuccinimide and N-Cbz-alpha-amino-N-alkoxysuccinimides were prepared from the corresponding (R)- or (S)-N-Cbz-aspartic acid through the known synthetic procedures. Their anticonvulsant activities in the MES and PTZ test were evaluated. All of these compounds except 3a showed significant anticonvulsant activities against the PTZ test, but these compounds were not active in the MES test. The most active compound in the PTZ test was (R)-N-Cbz-alpha-amino-N-benzyloxysuccinimide (ED50=62.5 mg/kg). In addition, the anticonvulsant activities of these compounds were dependent on their N-substited groups. The order of anticonvulsant activity against the PTZ test, as judged from the ED50 values for (R) series was N-benzyloxy > N-hydroxy > N-isopropoxy > N-methoxy > N-ethoxy; for the (S) series N-ethoxy > N-benzyloxy > N-methoxy > N-isopropoxy.


Asunto(s)
Anticonvulsivantes/síntesis química , Anticonvulsivantes/uso terapéutico , Convulsiones/tratamiento farmacológico , Succinimidas/síntesis química , Succinimidas/uso terapéutico , Animales , Evaluación Preclínica de Medicamentos/métodos , Masculino , Ratones , Ratones Endogámicos ICR
8.
Z Urol Nephrol ; 72(4): 237-47, 1979 Apr.
Artículo en Alemán | MEDLINE | ID: mdl-111438

RESUMEN

In the animal experiment should be made clear whether several medicaments which stood the test in the prevention of relapses of urinary calculi may be used without any danger also in the infantile carrier of concrements. For this purpose young rabbits high doses of diuretics, kation exchangers, aluminium oxide, extracts of the root of rubia tinctorum, succinimide and diphosphonate were given. Growth and development of the animals were negatively influenced by the medicaments, with the exception of the kation exchanger and the extracts of the root of rubia tinctorum. Numerous animals died under the administration of duiretics. The results of the examinations of metabolism only partly allow general conclusions. The medicamentous long-term metaphylaxis of the urolithiasis in childhood is also to be used like dietetic restrictions under strong indication and permanent control.


Asunto(s)
Crecimiento/efectos de los fármacos , Metabolismo/efectos de los fármacos , Cálculos Urinarios/tratamiento farmacológico , Óxido de Aluminio/efectos adversos , Óxido de Aluminio/uso terapéutico , Animales , Resinas de Intercambio de Catión/efectos adversos , Resinas de Intercambio de Catión/uso terapéutico , Diuréticos/efectos adversos , Diuréticos/uso terapéutico , Ácido Etidrónico/efectos adversos , Ácido Etidrónico/uso terapéutico , Hidroclorotiazida/efectos adversos , Hidroclorotiazida/uso terapéutico , Extractos Vegetales/efectos adversos , Extractos Vegetales/uso terapéutico , Conejos , Succinimidas/efectos adversos , Succinimidas/uso terapéutico
9.
Epilepsia ; 18(4): 543-8, 1977 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-579341

RESUMEN

Interictal spikes with a configuration similar to that occurring in grand mal epilepsy were generated by the application of penicillin to a hippocampal slice preparation. This slice preparation has potential value for screening anticonvulsant drugs and for studying epileptic activity. The effect of anticonvulsant drugs on seizure activity was tested at concentrations comparable to reported clinical serum concentrations. Phenytoin and diazepam were maximally effective at concentrations of 20 microgram/ml and 3-4 microgram/ml, respectively, in good agreement with their effective concentrations in clinical practice. Phenobarbital was more potent (5 microgram/ml) and mesuximide (50% potent at 80 microgram/ml) was least effective.


Asunto(s)
Anticonvulsivantes/uso terapéutico , Modelos Animales de Enfermedad , Hipocampo/fisiopatología , Convulsiones/tratamiento farmacológico , Animales , Diazepam/uso terapéutico , Evaluación Preclínica de Medicamentos/métodos , Electroencefalografía , Cobayas , Hipocampo/efectos de los fármacos , Técnicas In Vitro , Masculino , Penicilina G , Pentobarbital/uso terapéutico , Fenobarbital/uso terapéutico , Fenitoína/uso terapéutico , Convulsiones/inducido químicamente , Convulsiones/fisiopatología , Succinimidas/uso terapéutico
10.
C R Seances Soc Biol Fil ; 170(4): 750-3, 1976.
Artículo en Francés | MEDLINE | ID: mdl-137035

RESUMEN

An experimental study made on rat shows an inhibitrice activity of succinimide on formation of others kinds of urinary stones than those constituted with Ca oxalate and suggests the existence of a non specific anticrystallizing effect.


Asunto(s)
Succinimidas/farmacología , Cálculos Urinarios/tratamiento farmacológico , Animales , Calcio/análisis , Magnesio/análisis , Oxalatos/análisis , Fósforo/análisis , Ratas , Succinimidas/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA